Affiliated Cancer Hospital & Institute Of Guangzhou Medical University

This study tests a new combination of drugs for people whose ovarian cancer has returned after standard treatment. The drugs include a dual-target immunotherapy (QL1706), chemotherapy, and an oral anti-angiogenic agent (anlotinib). The goal is to see if this combo can shrink tumo…

This study tests a new drug called QL1706, given with chemotherapy, before surgery for women with locally advanced cervical cancer. The goal is to shrink tumors enough to allow complete removal. About 50 women will take part. The main focus is on whether the cancer disappears ent…

This study is testing a new radioactive tracer called 18F-FGln, which targets glutamine—a nutrient that cancer cells need to grow. Researchers want to see if PET/CT scans using this tracer can more accurately detect and stage various cancers, especially those that are hard to see…